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Oculocutaneous albinism (OCA) is a complex group of 
genetic disorders that have historically been defined by 
clinical and biochemical methods. Recent advances in 
the molecu�ar biology of pigmentation have greatlYi 
increased our understanding of the complexity of this 
group of disorders. To date, two diH'erent types of 
OCA (OCAl and OCA2) have been mapped to specific 
chromosomal regions. Mutations have been found in 
the tyrosinase locus associated with OCAI and the 
DEFINITION OF ALBINISM 
Albinism represents a group of inherited abnormalities of mela­
nin synthesis characterized as a congenital reduction or absence of 
melanin synthesis in association with specific ocular changes result­
ing from hypopigmentation in the developing eye [1,2]. These ocu­
lar changes include foveal hypoplasia, misrouting of the optic fibers 
as they course from the retina to the brain, and a reduction in visual 
acuity. Unlike the cutaneous pigmentation, which is variable with 
the different mutant alleles that are associated with albinism, the 
changes in the optic system are universal for all types of albinism and 
are a major part of the diagnostic criteria [3,4]. The color of the hair 
and skin or the presence or absence of the ability to tan are no longer 
sufficient for definition or recognition of albinism. 
Albinism has been broadly divided into two types, ocular albinism 
(OA) with primary involvement of the eye, and oculocutaneous 
albinism (OCA) with involvement of the skin, hair and the eye. 
OCA can be further divided into OCAl or tyrosinase related OCA, 
OCA2 or tyrosinase positive OCA, unclassified types (brown OCA, 
red OCA), and several types for which the primary defect is not 
limited to the melanocyte (Table I). OA presents as an X-linked 
recessive OA (OA1), associated with macromelanosomes in the 
melanocytes, or as autosomal recessive �A. At present, three ge­
netic loci involved in albinism have been mapped to specific chro­
mosomal regions (OCA1, OCA2 and OA1) and two of these genes 
have been isolated and mutations responsible for the OCA have 
been identified (OCA 1 and OCA2). This review will address OCA. 
TYROSINASE RELATED OCULOCUTANEOUS 
ALBINISM: OCAl 
Tyrosinase related OCA (OCA 1) is the result of the loss of function 
of tyrosinase in melanocytes because of mutations of the tyrosinase 
gene. There are several types of OCAl, each having a somewhat 
unique phenotype (Table 1). OCAlA or tyrosinase negative OCA 
has a totally depigmented phenotype [1,2] . Affected individuals 
have white hair and skin and blue irides throughout their life. All 
skin lesions are amelanotic. OCAlB or yellow OCA has a variably 
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human homologue to the murine pink-eyed dilution 
locus associated with OCA2. Analysis of these genes 
and their mutations will allow us to better define and 
categorize the different types of albinism. Further, the 
analysis of these genes and their mutations will provide 
information on the role of these gene products in mel­
anin biosynthesis and the effect specific mutations 
have on the pathogenesis of albinism.] Invest Demwtol 
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pigmented phenotype [5,6]. Affected individuals have white hair at 
birth and develop pigmented hair, yellow or blond, in the first 
decade of life. The skin remains white but may tan with sun expo­
sure and pigmented nevi and freckles may develop. OCAIMP or 
minimal pigment OCA is similar to OCAIB except that less pig­
ment is apparent and is usually localized to the iris with little change 
in hair or skin color [7]. Finally, OCA 1 TS or temperature sensitive 
OCA has a pigmentation phenotype characterized by the formation 
of melanin in hair located in cooler regions (arms and legs) of the 
body in a pattern similar to the Siamese cat [8,9]. As noted above, the 
cutaneous and even the iris pigment can be absent or moderate in 
amount in the different types of OCA1, but the ocular features are 
constant. 
An important distinguishing characteristic of OCAl is the pres­
ence of marked hypopigmentation at birth. Most individuals af­
fected with OCAl have white hair, milky white skin, and blue eyes 
at birth. During the first and second decade of life, the irides usually 
become a darker blue or blue-gray and the skin may appear to have 
more color, even in OCAlA. Sun exposure produces erythema and 
a burn if the skin is unprotected and a generalized tan is absent or 
minimal in most individuals with OCAL Few pigmented lesions 
(nevi, freckles, and letigines) develop in the skin. 
The locus for OCAl has been mapped to the tyrosinase locus 
(TYR) at chromosome llq14-21 and mutations in the tyrosinase 
gene are the cause of this genetic condition [10,11]. A series ofTYR 
mutant alleles have been identified, associated with a range of resid­
ual enzyme activity. Some alleles are associated with no enzyme 
function while others have residual or unusual activity. The recog­
nized phenotype can be explained by the effect of the mutation on 
tyrosinase activity, and this has allowed previously unclassified 
OCA types to be identified as OCAL 
TYROSINASE GENE MUTATIONS 
ASSOCIATED WITH OCAl 
We are currently using a combination of methods to detect muta­
tions responsible for OCAl including quantitation of tyrosinase 
activity, sin�le-stranded conformational polymorphism analysis 
(PCR-SSCP ) and fluorescence DNA sequencing. Analysis of the 
levels of tyrosinase activity is important to determine the type of 
OCA involved. Quantitation of tyrosinase activity is accomplished 
using the tritiated tyrosinase assay with hairbulb melanocytes as the 
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Table I. Classification of Oculocutaneous Albinism (OCA) 
Primary abnormality of melanin synthesis in the melanocyte 
OCAI; Tyrosinase Related OCA 
Mutations associated with no residual enzyme activity 
OCAlA: tyrosinase-negative OCA 
Mutations associated with residual enzyme activity 
OCAIB: yellow OCA 
OCAIMP: minimal pigment OCA 
Mutations associated with unusual enzyme activity 
OCAITS: temperature-sensitive OCA 
OCA2; tyrosinase positive OCA, Prader Willij Angelman Syndrome 
Unclassified types 
BrownOCA 
Rufous or red OCA 
Abnormality not limited to the melanocyte 
Hermansky-Pudlak syndrome 
Chediak-Higashi syndrome 
source of enzyme [12,13]. Reduced or absent levels of tyrosinase 
activity is one of the criteria for OCA1. Most obligate heterozygotes 
for OCAl have low hairbulb tyrosinase activity, but recent studies 
show that some mutant alleles produce sufficient residual activity to 
give carriers normal or near normal levels of hairbulb tyrosinase 
activity. If tyrosinase activity levels of the affected individual indi­
cate that OCAl is the type of albinism involved, then their tyrosin­
ase gene is analyzed for mutations. 
For analysis of the tyrosinase gene, each of the five exons are first 
screened for mutations using PCR-SSCP [14-16]. This method 
provides detection of point mutations in DNA by observing mobil­
ity shifts in single stranded DNA on a non-denaturing polyacrylam­
ide gel that results from the changes in the nucleotide sequence [15]. 
Each exon is individually amplified using the polymerase chain 
reaction (PCR), denatured, and the strands separated by electropho­
resis. Amplification primers hybridize to the flanking intron se­
quences allowing the entire coding region and the intron/ exon 
boundaries to be analyzed. When an exon exhibits altered electro­
phoretic mobility, alterations in the sequence are determined using 
automated fluorescence infrared DNA sequencing [16]. 
The amplified exon used in PCR-SSCP analysis is also used as the 
template for di-deoxy sequencing employing a cycle-sequencing 
protocol [16]. The sequencing primers are fluorescently tagged 
with fluors that emit in the infrared region of the spectrum. The 
sequencing ladder is analyzed using an automated fluorescence 
DNA sequencer (LI-COR model 4000). The resulting nucleotide 
sequence is then compared to the normal tyrosinase sequence and 
changes noted. The combination of PCR-SSCP with fluorescent 
di-deoxy DNA sequencing allows for the fast and accurate detection 
of mutations in the proband and for the determination of the carrier 
status of relatives. The advantages to this system are the elimination 
of radioisotopes for detection of both the PCR-SSCP analysis and 
sequencing and the quickness and ease of these techniques. 
A large number of mutations of the tyrosinase gene have been 
identified (Table n) [17,18]. Most are single-base substitutions that 
produce an amino acid substitution in the protein. Less frequent are 
base substitutions that create a stop codon and one-, two- or four­
base insertions or deletions that alter the reading frame and produce 
a truncated protein. More recently, a number of single-base substi­
tutions that alter a splice donor or acceptor site have been identified. 
Most individuals with OCAl in the u.s. population have been 
compound heterozygotes with a different maternal and paternal 
mutation. Individuals who are homozygous for a single mutation 
have often come from small populations or from consanguineous 
matings. In approximately 15% of the individuals who are com­
pound heterozygotes, only one of the two mutant alleles has been 
identified. In these cases, the individual is heterozygous for this 
mutation, showing that a second mutation must be present. Possi­
bilities for the second mutation are cryptic splice sites, gross ge­
nomic rearrangements undetected by sequencing, or mutations in 
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the 5' promoter site. Evidence has been accumulating that there are 
important regulatory regions several kilobases 5' of the promoter 
region. Different analytical methods will be needed to detect these 
different possibilities. 
The majority of mutations identified to date produce a totally 
inactive enzyme or no enzyme protein, and these are associated with 
OCAlA, and with a total life-long inability to synthesize melanin 
in any melanocyte. There has been a strong bias in selecting individ­
uals with OCAlA for analysis because this phenotype is the most 
obvious clinically. A small number of mutations have been found 
with OCA1MP and OCAIB, both pigmenting types of OCA. It is 
hypothesized that these mutations produce enzymes with some re­
sidual activity, accounting for the melanin synthesis. The yellow or 
blond hair color of OCAIB is thought to be the result of small 
amounts of DOP Aquinone being made in the initial steps of the 
melanin pathway, followed by the rapid reaction of this compound 
with sulfhydryl compounds to form cysteinylDOPA and eventually 
pheomelanin. 
OCA IB is quite variable in degree of hypo pigmentation, varying 
from very little pigment associated with whitish-blond hair to 
nearly normal pigment with dark blond hair and skin that tans well. 
The variability will likely be the result of the amount of residual 
tyrosinase activity [6] and the genetic pigment constitution of the 
affected individual. Some mutant alleles are associated with sufli­
cient residual activity to produce moderate amounts of cutaneous 
pigment, but all mutant alleles are associated with insufficient ocu­
lar pigment for normal foveal and optic tract development. One 
mutation has been found with OCAITS or temperature sensitive 
OCA, and the activity of the mutant tyrosinase enzyme was tem­
perature sensitive, with reduced activity above 35°C [8,9]. 
Further genetic complexity comes from the fact that most af­
fected individuals are compound heterozygotes. As a result, an indi­
vidual may have two different mutant alleles that code for inactive 
enzyme, one mutant allele coding for inactive enzyme and one 
mutant allele coding for enzyme with residual activity, or two dif­
ferent mutant alleles that code for enzyme with residual activity. 
Clinical and biochemical analysis will not elucidate this type of 
complexity, and molecular analysis is the only accurate method of 
specific diagnosis. 
ANALYSIS OF THE TYROSINASE MUTATIONS 
Tyrosinase (EC 1.14.18.1) is a bicupric enzyme responsible for the 
first two steps in the melanin-synthesis pathway; the hydroxylation 
of tyrosine to L-3,4-dihydroxyphenylalanine (DOPA) and the oxi­
dation of DOPA to DOPAquinone [19]. The first reaction, tyrosine 
to DOPA, requires the presence of molecular oxygen, which first 
forms a peroxide with the two copper atoms. This complex com­
pound then reacts with the 3 or 5 carbon atom of tyrosine resulting 
in the addition of a hydroxyl group forming DOPA. The two hy­
droxyl groups are then oxidized to produce DOPAquinone. It has 
also been hypothesized that the formation of DOPAquinone from 
tyrosine occurs as a single step resulting from a ligand substitution 
between the bound dioxygen with the newly formed diphenol 
which is then subsequently released as DOPAquinone [20,21]. A 
third activity, 5,6-dihydroxyindole (DRI) oxidase has also been 
ascribed to tyrosinase but the biologic role of this activity is un-
known [22,23]. 
. 
Analysis of the mutations of the tyrosinase gene in individuals 
with OCA 1 has revealed that the identified missense mutations 
cluster into four regions of the tyrosinase gene (Fig 1) [24]. It is felt 
that these clusters define important functional regions of tyrosinase 
involved in the catalytic activity of the enzyme. Two of these re­
gions are the copper A and copper B binding sites containing codons 
172-223 for copper A and 352-401 for copper B. The missense 
mutations found in the two copper binding sites are listed in Table 
m [17,25]' Each copper binding site consists of two a-helical re­
gions and a loop structure between the two a-helices. The purpose 
of the two a-helices is to orient the three histidine residues so they 
can complex with a copper atom. The two copp'er binding sites 
bring the two copper atoms to a distance of 3.6 A as observed in 
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Tablell. Mutations and Polymorphisms Associated with OCAl 
Mutation 
P21Sb 
D42G 
G47D 
C55Y 
R77Q 
P81L 
C89R 
+AA96 
-i\GAl15 
F176I 
W178X 
-i\G191 
Y192S 
A206T 
L216M 
R217W 
R217Q 
W236X 
-i\TG244 
V275F 
R299H 
+i\C310 
H367R 
N371T 
T373K 
Q378X 
N382K 
D383N 
-i\T388 
R402Q 
R403S 
P406L 
G419R 
R422Q 
-i\CTTT438 
G446S 
D448N 
Q453X 
+i\T489 
+i\C501 
• Poly, polymorphism. 
Base 
Change(s) 
CCT ...... TCT 
GAC ...... GGC 
GGC ...... GAC 
TGT ...... TAT 
CGG ...... CAG 
CCT ...... CTr 
TGC ...... CGC 
ATGb ...... XATG 
AGA ...... A-=-
TTT 
...... ATT 
TGG ...... TAG 
GGA ...... -GA 
TAT ...... TCT 
GCT ...... ACT 
TrG ...... ATG 
CGG ...... TGG 
CGG ...... CAG 
TGG ...... TAG 
TGTG ...... TG--
GTC ...... TTC 
CGT ...... CAT 
CCA ...... CCCA 
CAC ...... CGC 
AAT ...... ACT 
ACA ...... Ai\A 
CAG ...... TAG 
AAC ...... i\AA 
GAT ...... AAT 
CTT ...... CT-
CGA ...... CAA 
AGG ...... AGT 
ccr ...... CTI 
GGA ...... AGA 
CGG-+CAG 
cfiT ...... --=--
GGC ...... AGC 
GAC ...... i\AC 
CAA-+TAA 
ACT ...... ACTT 
CGT ...... C�GT 
I The start codon ATG (Methionine) is counted as codon 1. 
Base Type 
Change OCAI Population 
Pro ...... Ser A Caucasians 
Asp ...... Gly A Caucasians 
Gly ...... Asp A Caucasians and Hispanics 
Cys ...... Tyr A Caucasians 
Arg ...... Gln A Japanese 
Pro ...... Leu A Caucasians 
Cys ...... Arg A Blacks 
Te?Il 168 A Caucasians 
;ferm 167 A Pakistani 
Phe ...... I1e A Caucasians 
Trp ...... Ter A Mghans 
Term 225 A Caucasians 
Tyr ...... Ser Pol}'" All except Orientals 
Ala ...... Thr A Caucasians 
Leu""" Met A Hispanics 
Arg ...... Trp A Caucasians 
Arg ...... Gln A Caucasians 
Trp ...... Ter A Blacks 
Term 244 A Caucasians 
Val ...... Phe B Caucasians 
Arg ...... His A Caucasians 
Term 317 A Japanese 
His ...... Arg A Caucasians 
Asn ...... Thr A Caucasians 
Thr ...... Lys A Caucasians 
Gln ...... Ter A Caucasians 
Asn ...... Lys A Caucasians 
Asp ...... Asn A Caucasians 
Term 484 A Caucasians 
Arg ...... Gln Pol}'" All except Orientals 
Arg ...... Ser B Caucasians 
Pro ...... Leu B Caucasians 
Gly ...... Arg A Caucasians 
Arg ...... Gln TS Caucasians 
Term 484 A Caucasians 
Gly ...... Ser A Caucasians 
Asp ...... Asn A Caucasians 
Gln ...... Ter A Caucasians 
Term 509 A Caucasians 
Term 509 A Caucasians 
Neurospora tyrosinase, which permits the copper atoms to form a 
peroxide [26]. Site directed mutagenesis experiments on the Strepto­
myces glaucescens tyrosinase gene has shown the importance of the 
histidine residues on tyrosinase activity and as copper ligands 
[27,28]. 
mutation F1761 in the putative copper A binding region affects a 
phenylalanine in the motifPhe-X-X-X-His. The phenylalanines in 
both motifs are thought to be important in the correct positioning of 
the histidine ligands. The other three mutations are within the 
a-helix next to the codon 211 histidine ligand. 
Comparison of the amino acid sequences between the copper 
binding sites of several tyrosinase and hemocyanin polypeptides 
shows that these regions are highly conserved, including two iden­
tifiable amino acid motifs [29]. Missense mutations in the copper A 
binding region can be found within both of these motifs. The 
A206T mutation affects a motif found in both copper-binding re­
gions (Pro-X-Phe-X-X-X-His) substituting a threonine for an ala­
nine located between the proline and phenylalanine residues. The 
Figure 1. Clustering of the missense mutatioDS of the tyrosinase 
gene. The five boxes represent the exons of the tyrosinase gene. The striped 
regions represent the two putative copper binding regions and the shaded 
region is the signal peptide. The arrows show the location of the missense 
mutarions. The horizontal bars represent putative functional domains of the 
tyrosinase enzyme. 
We have previously reported on the effect of mutations in the 
Table m. Missense Mutations in the Tyrosinase Copper 
Binding R.egions 
Mutation 
Copper (A) 
F1761 
A206T 
L216M 
R217W 
R217Q 
Copper (B) 
H367R 
N371T 
T373K 
N382K 
D383N 
Base 
Change 
TTT-+ATT 
GCT .... i\CT 
TTG ...... ATG 
CGG .... TGG 
CQG ...... CAG 
CAC-+CGC 
AAT-+ACT 
ACA ...... Ai\A 
AAC-+AAA 
QAT""" !!AT 
Codon 
Change 
Phe-+Ile 
Ala ...... Thr 
Leu-+Met 
Arg ...... Trp 
Arg ...... Gln 
His ...... Arg 
Asn ...... Thr 
Thr ...... Lys 
Asn ...... Lys 
Asp ...... Asn 
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Figure 2. Structure of the copper B binding region of Panulirus 
interruptus hemocyanin. The copper B atom is the single atom in the 
center of the figure. The three histidine ligands held in place by the two 
a-helices are represented as ball-and-stick figures. The a-helices are the two 
coiled structures. The arrows show the homologous codon location of the 
human tyrosinase mutations associated with OCA1. This image was con­
structed from the three-dimensional coordinates of Panulirus interruptus he­
mocyanin using the MOLSCRIPT software [30,31,33]. 
copper B binding region on the secondary structure of tyrosinase 
[25). We have done further analysis of this region using �he known 
three-dimensional structure of the arthropod hemocyanm of Panu­
lirus interruptus [30,31). Comparisons between tyrosinase and he­
mocyanin for both the primary structure and the predicted second­
ary structure show that they are very similar within the copper 
B- binding region [25,32). This makes hemocyanin a good model 
to study how mutations might affect this same region in tyrosinase. 
Figure 2 shows the folding structure of the copper B binding re­
gion of hemocyanin [33). As can be seen in this model, the two 
a-helices, connected by a loop region, hold the three histidine lig­
ands in place. Four mutations, N371T, T373K, N382K and 
D383N, are at or near the junction of the a-helix and the loop 
region (arrows) . Computer analysis of the secondary structure of the 
loop region shows that the incorporation of these mutations into the 
primary amino acid sequence will alter this structure, when com­
pared to the normal amino acid sequence [�5). M?st �ikely the�e 
mutations affect the orientation of the a-hehx, which m turn Will 
either affect the location or the binding of the copper atom by the 
histidine ligands. The copper to copper distance is critical for enzy­
matic activity and any alteration of this distance would render the 
enzyme inactive, due to its inability to form a peroxide with molec-
ular oxygen. . . A fifth mutation was found at codon 367 (H367R), which substi­
tutes an arginine for a histidine residue (Fig 3). This histidine is one 
of the three copper ligands in the copper B - binding region. As was 
shown in the site-directed mutagenesis analysis of the Streptomyces 
glaucescens tyrosinase gene, elimination of one of these histidines 
will result in an inactive enzyme [28]. The chemistry and size of the 
arginine residue is such that it would not be able to complex with 
the copper atom and the other two histidine ligands alone are �ot 
sufficient to bind the copper atom in the correct orientation relative 
to the copper A atom [28). 
There are two other clusters, one in exon 4 next to the copper B 
cluster and one at the amino terminal end of the polypeptide (Fig 1). 
The cluster in exon 4 contains mutations that have residual activity 
(R403S, P406L) and the temperature-sensitive mutation (R422Q). 
This cluster is close to the active site because of its proximity to the 
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copper B binding region and would most likely be involved in 
substrate binding. The binding of tyrosine and DOPA must occur 
next to the copper atoms and the substitution of a single amino acid 
side chain in this region would be enough to prevent substrate 
binding. The residual activity mutations may restrict but not abolish 
substrate binding so that some activity is present. 
Analysis of the amino-terminal end of hemocyanin shows that 
this region of the polypeptide interacts with the two copper-bind­
ing sites. This may also be the case in tyrosinase and could explain 
the amino terminal cluster of mutations. The amino terminal end of 
the tyrosinase molecule may play a role in forming the substrate­
binding site and mutations in this cluster could affect activity by 
altering the structure of the catalytic site of the enzyme. It has also 
been hypothesized that there may be two active sites, one responsi­
ble for DOPA oxidase and DHI oxidase activity and one responsible 
for tyrosine hydroxylase activity [23). If this is true, then the amino­
terminal cluster and the exon 4 cluster may represent mutations that 
are affecting these two different active sites. 
These mutations are revealing the complex chemistry of melanin 
synthesis by tyrosinase. As other mutations are found and their 
effect on the catalytic activity of tyrosinase determined, we should 
have a better understanding of the role tyrosinase plays in melanin 
formation including how mutations cause the different phenotypes 
observed. 
TYROSINASE POSITIVE OCULOCUT ANEOUS 
ALBINISM: OCA2 
The general phenotypic features of tyrosinase positive oculocu­
taneous albinism or OCA2 include the presence of hair and iris 
pigment, and the development of localized (nevi, freckles and leti­
gines) skin pigment, often in sun-exposed regions of the skin [2). 
The ethnic and constitutional pigment background of an affected 
individual has a more profound effect on OCA2 than on OCAL 
The phenotype of type OCA2 varies such that the cutaneous 
hypopigmentation can be subtle in some and obvious in others. 
Several generalizations about OCA2 can be made. First, individuals 
with OCA2 usually have pigmented hair at birth, which is in con­
trast to OCAL Second, the skin is white but it usually has a creamy 
rather than a milky color, and the eyes are blue or blue-gray. Third, 
the amount of pigment in the skin, hair, and eyes generally increases 
with age but rarely reaches an amount that would be considered 
normal for an unaffected family member. More importantly, af­
fected individuals from more darkly pigmented populations have 
clinically apparent hypopigmented skin and hair throughout their 
life, while those from lightly pigmented populations, particularly 
those of northern Europe ( i.e., Scandinavian), may not appear to 
Figure 3. Orientation of the three histidine residues and the copper 
(B) atom. The figure on the left represents the normal complex and the 
figure on the right shows the arginine substitution associated with the 
H367R mutations. This image was constructed from the three-dimensional 
coordinates of P. interruptus hemocyanin using the UCSD Molecular Mod­
eling System (MMS) software [30,31]. 
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have significant cutaneous hypopigmentation associated with the 
ocular features of albinism. Fourth, hairbulbs from an individual 
with OCA2 form pigment when incubated in tyrosine or DOPA, 
and the �el�n.
is
. 
synthes�zed in the melanosomes [34-36]. 
Caucasian mdlv1duals w1th OCA2 have creamy white skin and 
may have pigmented birth marks. There is no change in the general 
skin colo
.
r wit� time an� a ta� does not develop after sun exposure, 
but loc�hzed p1gment.
( 1.e., plg
.
mented ne�, freckles) may develop. 
The halr �an be very hght at birth, appearmg nearly white or light 
blond, or 1t can be blond, golden blond, reddish blond, or brown. 
The iris is blue to blue/gray, and transillumination of the globe 
often reveals pigment at the pupillary border with strands of pig� 
me
.
nt C?ursing through the iris like the spokes of a wagon wheel. 
W1th time the amount of hair and iris pigment often increases and 
the affected individual may not appear to have albinism unless the 
eyes and skin are carefully examined. 
In Africa�-A��rican and African individuals, the phenotype of 
type
.
OCA2 1S �s�mct, .and see� t<? represent one genetic type [35]. At bIrth the skm IS wh1te, the harr 1S yellow, and the irides are blue. 
With time the hair turns a darker yellow and pigmented nevi and 
lentigines develop in the skin, although there is no tan. The itis 
�olor r��ains blue o� turns tan or light brown and there is pigment 
10 the IDS at the pupIllary border and coursing through the stroma 
[35]. 
Hairbulb tyrosinase from individuals with OCA2 has normal 
activity and a normal electrophoretic pattern [13,36-38], and the 
defect in this type of OCA is not in the tyrosinase gene. The locus 
for OCA2 has been mapped to chromosome 15q11.2-q12 and the 
human homologue of the mouse pink-eyed dilution gene has also 
been lo�alized to this region and has now been shown to be the gene 
respons1ble for OCA2. Molecular analysis of this gene, both its 
normal function and mutations involved in OCA2 has just begun 
[39-44]. 
A newly recognized association with OCA2 is the hypopigmen­
tation found with Prader-Willi syndrome (PWS) and Angelman 
Syndrome (AS) [45-48]. PWS is a developmental syndrome that 
includ�s neonatal hypotonia, hyperphagia, and obesity, hypo­
gonadIsm, small hands and feet, and mental retardation associated 
with characteristic behavior [49,50]. Approximately 70% of indi­
viduals with PWS have a deletion on the long arm of the paternal 
chromosome 15 [45,51], and most of those without a deletion of the 
paternal chromosome 15 have uniparental disomy for the maternal 
chromosome 15 [52,53]. 
Approximately 50% of individuals with PWS are hypopig­
mented but most do not have the typical ocular features of albinism 
[47 -49]. Interestingly, a number of individuals with PWS and 
OCA have been identified [42]. For those without obvious OCA, 
hair and skin are lighter than unaffected family members, and child­
hood nystagmus and strabismus are common but often transient. 
The irides are pigmented with some translucency on globe transil­
lumination, and retinal pigment is reduced in atnount . Although 
fov�al hypoplasia is not usually present, the fovea may not appear 
entirely normal [50]. Visual evoked potential studies have revealed 
optic tract misrouting similar to that found in albinism in some 
individuals with PWS and hypopigmentation [54]. This is an im­
portant observation because the presence of optic tract abnormalities 
!m�lie� pathologic hypopigmentation during development, thus 
md1catmg that the hypopigmentation in PWS is best described as a 
type of albinism. The individuals with PWS and OCA have not 
been fully described, but the feames of the albinism are typical for 
OCA2. 
Individuals with AS are also hypopigmented, but the percentage 
showing this ph�notypic characteristic is unkn?wn [42,48]. Angel­
man Syndrome 1S a complex developmental disorder that includes 
developmental de�ay and
. 
severe mental ret�dation, microcephaly, 
neonatal hypo�oma, atax1C movements, and 1nappropriate laughter 
[55]. Those w1th hypopigmentation have light skin and hair and 
may have a history of nystagmus or strabismus [48]. Iris translu­
cency and reduced retinal pigment may be present. No analysis of 
the optic tract organization is available. 
MOLECULAR BASIS OF ALBINISM 13SS 
PINK-EYED DILUTION GENE 
The gene responsible for OCA2 has been identified as the human 
h?mologue to .the mouse pink-eyed dilution (p) gene [39-42]. Two different deletIons of the human P gene responsible for OCA2 have 
so far been identified in individuals with both PWS and OCA2. 
Southern blot analysis revealed that the maternally derived chro­
mosome 15 contained a partial deletion of the P locus (the last exon 
of the P gene) and karyotype analysis demonstrated a de novo dele­
tio� of15qll-q13 that included the entire P locus on the paternally 
denved chromosome [42]. A common 2.7-kb deletion of a single 
exon of the P gene has been identified in OCA2 individuals from 
the Brandywine isolate in Maryland, from unrelated African-Amer­
ican �div�duals, and from African individuals, showing that this 
mutatIon 1� co
.�
on �nd has an African origin [44]. More impor­
tantly� the mdiv1duals 10 the Brandywine isolate were homozygous 
f?r this mutant allele, providing unequivocal evidence that muta­
tions �f the P gene are responsible for OCA2. Five different point 
mutations of the P gene associated with OCA2 have also been 
reported [43]' It has been hypothesized that the function of the P 
loc� produ�t may be a ty�osine transporter, and this would be 
conslStent w1th the observation that fresh hairbulbs from individu­
als affected with OCA2 from melanosomal pigment when the hair­
b
.
ul�s �e incubated in tyr�sine (or DOPA). However, the reported 
simil�ty or the P p.rotem sequence to a bacterial tyrosine trans­
porter 1S �eak. �tudles are currently being carried out by several 
groups to mves�lgate the function of this protein. 
The mechanlsm for the hypopigmentation in PWS and AS in 
tho
.
se individuals
. 
without �bvious OCA has not been fully ex­
plamed. The munne p locus 1S not imprinted and it is likely that the 
hum.an locus is not [40]. The deletion on the paternal chromosome 
15q 10 PW:S and th� mate� chromosome 15q in AS suggests that 
the hypop1gmentation anses from a mechanism other than gene 
dose effect, because hete�ozygotes for OCA2 are normally pig­
mented. Further work wdl be necessary after the function of the 
gene product of the P locus is determined. 
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